(AKYA) Akoya Biosciences - Performance -69.1% in 12m
Compare AKYA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-76.05%
#167 in Group
Rel. Strength 12m
5.92%
#7364 in Universe
Total Return 12m
-69.14%
#179 in Group
Total Return 5y
-94.24%
#169 in Group
12m Total Return: AKYA (-69.1%) vs XLV (0.9%)
5y Drawdown (Underwater) Chart
Top Performers in Health Care Equipment
Overall best picks of Peer Group (based on Performance, Valuations and Relative Strength)
| Symbol | 1m | 12m | 5y | P/E | P/B | Growth Rating |
|---|---|---|---|---|---|---|
| SNT WAR Synektik S.A. |
-7.05% | 42.2% | 2,033% | 21.98 | 7.95 | 94.51 |
| KEQU NASDAQ Kewaunee Scientific |
-28.0% | 54.7% | 492% | 6.80 | 2.39 | 87.00 |
| ABT NYSE Abbott Laboratories |
-2.99% | 8.79% | 87.9% | 17.93 | 4.92 | 51.93 |
| PDEX NASDAQ Pro-Dex |
40.2% | 185% | 238% | 17.37 | 3.45 | 50.62 |
| RMD NYSE ResMed |
-3.79% | 18.0% | 69.6% | 25.97 | 6.16 | 41.44 |
Performance Duell AKYA vs XLV
| Total Return (including Dividends) | AKYA | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -35.06% | 0.09% | -7.69% |
| 3 Months | -38.02% | 4.51% | -6.94% |
| 12 Months | -69.14% | 0.88% | 10.70% |
| 5 Years | -94.24% | 92.03% | 153.10% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #182 | -35.1% | -29.7% |
| 3 Month | #171 | -40.7% | -33.4% |
| 12 Month | #180 | -69.4% | -72.1% |
| 5 Years | #166 | -95.5% | -96.0% |
| Trend Score (consistency of price movement) | AKYA | XLV | S&P 500 |
| 1 Month | -93.3% | 8.1% | -96% |
| 3 Months | -60.1% | 81.6% | -21% |
| 12 Months | -40.3% | 23.2% | 91% |
| 5 Years | -94% | 90.5% | 84.5% |
FAQs
Does AKYA Akoya Biosciences outperforms the market?
No,
over the last 12 months AKYA made -69.14%, while its related Sector, the Health Care Sector SPDR (XLV) made 0.88%.
Over the last 3 months AKYA made -38.02%, while XLV made 4.51%.
Over the last 3 months AKYA made -38.02%, while XLV made 4.51%.
Performance Comparison AKYA vs Indeces and Sectors
AKYA vs. Indices AKYA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3.38% | -27.4% | -49.6% | -79.8% |
| US NASDAQ 100 | QQQ | -3.19% | -24.2% | -50.6% | -79.0% |
| US Dow Jones Industrial 30 | DIA | -2.65% | -28.4% | -49.4% | -77.4% |
| German DAX 40 | DAX | -5.65% | -37.3% | -72.3% | -96.6% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -8.92% | -37.8% | -74.1% | -84.5% |
| Hongkong Hang Seng | HSI | -4.79% | -42.0% | -64.4% | -83.6% |
| India NIFTY 50 | INDA | -5.31% | -33.7% | -33.7% | -66.3% |
| Brasil Bovespa | EWZ | -9.77% | -33.1% | -39.1% | -55.3% |
AKYA vs. Sectors AKYA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.96% | -26.8% | -59.6% | -91.1% |
| Consumer Discretionary | XLY | -1.30% | -21.7% | -51.8% | -79.4% |
| Consumer Staples | XLP | -1.62% | -33.7% | -44.6% | -77.3% |
| Energy | XLE | -8.32% | -34.7% | -54.4% | -70.7% |
| Financial | XLF | -4.44% | -28.7% | -57.4% | -89.8% |
| Health Care | XLV | -2.75% | -35.2% | -41.9% | -70.0% |
| Industrial | XLI | -3.34% | -30.4% | -49.7% | -78.2% |
| Materials | XLB | -3.56% | -30.8% | -41.8% | -65.6% |
| Real Estate | XLRE | -3.26% | -33.6% | -42.0% | -79.0% |
| Technology | XLK | -3.56% | -24.2% | -46.7% | -72.3% |
| Utilities | XLU | -7.70% | -34.8% | -50.2% | -97.6% |
| Aerospace & Defense | XAR | -6.17% | -30.9% | -55.5% | -87.7% |
| Biotech | XBI | -5.47% | -30.4% | -35.0% | -61.5% |
| Homebuilder | XHB | -1.37% | -26.5% | -30.2% | -62.6% |
| Retail | XRT | 0.21% | -20.2% | -39.0% | -60.3% |